novo-nordisk-logo

European Dividend Aristocrat Novo Nordisk reports 9.0% revenue growth in Q4

European Dividend aristocrat and Danish pharmaceutical company Novo Nordisk AS (NOVO-B.CO) reported on Wednesday a revenue growth of 9.0% and 4.8% earnings-per-share growth in Q4. Net profit in Q4 rose to 8.72 billion DKK ($1.29 billion) from DKK8.5 billion a year earlier. Sales in Q4 rose to DKK32.42 billion against analysts’ expectations of DKK31.95 billion.…

dax

Data on all 30 DAX stocks available

The DAX is a European index comprised of the 30 largest and most traded companies in Germany. It represents around 80 percent of the market capitalization of listed stock corporations in Germany. The DAX-index can be a great source for investors that are looking for European blue-chip dividend stocks. Members have direct access to detailed…